Published Technical Disclosure Archive

Enhanced Topical Copper Ion Treatments for Dermatological Conditions

Publication ID: 24-11857514_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Topical Copper Ion Treatments for Dermatological Conditions,” Published Technical Disclosure No. 24-11857514_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857514_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,514.

Summary of the Inventive Concept

The invention presents a suite of innovative solutions that improve the efficacy, safety, and convenience of topical copper ion treatments for dermatological conditions, addressing the limitations of existing treatments.

Background and Problem Solved

The original patent disclosed topical copper ion treatments for dermatological conditions, but these treatments had limitations, such as limited bioavailability, lack of controlled release, and inadequate personalized dosing. The new inventive concept addresses these limitations by introducing wearable devices, synergistic agents, biocompatible carrier materials, and personalized dosing.

Detailed Description of the Inventive Concept

The new inventive concept comprises four key innovations: (1) a wearable device for controlled release of copper ions, adapted for use on specific anatomical areas of the body; (2) a method for enhancing the efficacy of topical copper ion treatments by adding synergistic agents that increase bioavailability; (3) a topical copper ion treatment composition with a biocompatible carrier material for transdermal delivery; and (4) a device for administering topical copper ion treatments with real-time efficacy monitoring and personalized dosing. These innovations improve the treatment's penetration, efficacy, and safety, while also enhancing the user experience.

Novelty and Inventive Step

The new claims introduce novel and non-obvious solutions that significantly improve the existing topical copper ion treatments, including the use of wearable devices, synergistic agents, and biocompatible carrier materials. These innovations overcome the limitations of the original patent and provide a substantial improvement in the treatment of dermatological conditions.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of wearable devices, such as patches or implants, or the incorporation of additional synergistic agents or carrier materials. Variations could also include the development of customized treatments for specific skin types or conditions.

Potential Commercial Applications and Market

The enhanced topical copper ion treatments have significant commercial potential in the dermatological and cosmetic industries, with potential applications in the treatment of acne, wound care, and skin rejuvenation. The market for these treatments is substantial, with an estimated global value of over $10 billion.

CPC Classifications

SectionClassGroup
A A61 A61K33/34
A A61 A61K9/0014
A A61 A61K9/0031
A A61 A61K9/0034
A A61 A61K9/02
A A61 A61K9/06
A A61 A61L15/44
A A61 A61L17/005
A A61 A61L26/0066
A A61 A61L26/0076
A A61 A61L2300/102

Field of Art

Dermatological treatments, pharmaceutical compositions, and topical drug delivery systems, with expertise in copper ion-based therapies and transdermal drug formulations

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or biomedical engineering, having knowledge of drug delivery mechanisms, skin physiology, and formulation techniques for topical treatments

Obviousness Rationale

A person having ordinary skill in the art would recognize that the PTD's innovations represent predictable variations of the source patent's core copper ion treatment methodology. The disclosed wearable devices, synergistic agents, and personalized delivery mechanisms are logical extensions of existing topical drug delivery technologies. These variations would be considered obvious improvements that address known limitations in transdermal treatment approaches.

Obvious Combinations & Variations

Source Patent Element
Copper ion suspension applied to anatomical tissue for treating bacterial infections
PTD Variation
Wearable device for controlled release of copper ions on specific body areas
Obviousness Reasoning
Predictable design variation using known transdermal delivery technologies to improve localized treatment precision and patient convenience
Source Patent Element
Topical treatment in various formulations like cream, gel, and spray
PTD Variation
Biocompatible carrier material for enhanced transdermal penetration
Obviousness Reasoning
Known technique of improving drug delivery through advanced carrier materials that increase bioavailability and skin penetration
Source Patent Element
Treatment method for bacterial infections using copper ion suspension
PTD Variation
Adding synergistic agents to enhance copper ion treatment efficacy
Obviousness Reasoning
Routine optimization of pharmaceutical compositions by incorporating known enhancing agents to improve treatment performance
Source Patent Element
Topical treatment applied to anatomical tissue
PTD Variation
Real-time efficacy monitoring device with personalized dosing capabilities
Obviousness Reasoning
Predictable application of sensor technologies to pharmaceutical delivery systems for improved treatment customization
Source Patent Element
Copper ion suspension for treating dermatological conditions
PTD Variation
Method for personalizing treatment based on individual skin type and condition
Obviousness Reasoning
Obvious extension of personalized medicine approaches using standard diagnostic and formulation techniques
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would be considered obvious to a person having ordinary skill in the art in light of US Patent 11857514, as the claimed innovations represent predictable modifications and combinations of known techniques in topical copper ion treatment methodologies, with no evidence of unexpected results or non-obvious technical achievements.

Original Patent Information

Patent NumberUS 11,857,514
TitleTopical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
Assignee(s)CDA RESEARCH GROUP, INC.